Frequently Asked Questions

We have provided two lists of potential questions. The first list is for potential patients, and the second list is for doctors/medical professionals who wish to know more about this treatment. 



For Patients

Q1.What is RFQMR?

Ans. RFQMR is a State-of-the-Art Therapeutic Device based on Rotational Field Quantum Magnetic Resonance (RFQMR) which utilizes highly complex electromagnetic beams in the radio frequency spectrum controlled by a computer and guided by MRI. 


The beams are precisely controlled and focused onto tissues to alter the cell membrane potential of the target tissue cells which in turn stimulates cartilage growth in case of degenerative diseases such as Osteo arthritis or triggers the programmed cell death and stops the tumor's growth in Cancer.


RFQMR looks like a MRI machine and is the world's first Rotational Field Quantum Magnetic Resonance (RFQMR) Generator for Tissue Regeneration, Degeneration and Repair for treating several chronic or degenerative diseases such as Cancer & Arthritis. The treatment is non-invasive, painless and free from side effects. Clinical studies have demonstrated that RFQMR is very effective in curing certain conditions such as a damaged knee by regenerating the cartilage tissue or stopping and reversing the growth of a tumor in cancer. 


Q2. How does RFQMR work?

Ans. RFQMR therapy is a non-surgical / non-invasive treatment which aides in cellular regeneration, cartilage regeneration, and tumour destruction. The therapy is harmless, painless, devoid of any side effects, and completely safe.


RFQMR produces a high power multi-frequency, high energy spinning quantum electromagnetic beams in the lower end of Electromagnetic spectrum in the Sub-Radio and Near-Radio Frequencies. This frequency range effects are predominantly non-thermal because the intensity is not high enough to significantly change tissue temperature.The RFQMR device delivers programmed precise dose of RF beams in the 1Khz to 10 MHz Range in the presence of high instantaneous magnetic field, which is focused in the near field, using special antennae.


The manufacturers by simulation established that, when a biological Cell is exposed to such HF / RF under an instantaneous magnetic field it alters many cell parameters, including its resting Trans Membrane Potentials (TMP). Cellular activity is closely linked with the TMP that plays an Important role in the synthesis of proteins and it plays a significant role in the basic mechanism of mitosis (cell division) control. Trans Membrane Potential (TMP) is altered in different situations:

-70 to -90 mV is the TMP in Healthy Cells.

-40 to -60 mV when Infected.

-20 to -30 mV in Cancer Cells

0 mV when the Cell dies.


Q3. Is RFQMR comfortable and safe?

Ans. Patients feel no pain or discomfort during treatment. The RFQMR System has been cleared for its safety standards and is certified by DRDO, Government of India as safe, non-ionizing and non-thermal complying with the International Commission of non-ionizing Radiation standards


Q4. How is RFQMR Therapy conducted?

Ans. A patient lies on a bed that moves into the focus area (the RFQMR machine). The treating rays are focused on the arthiritic joints / tumor with laser guides and the computer calculates the dose based on the MRI, The treatment is usually one hour daily for 28 days.     


Q5. Are there any side effects to this treatment?

Ans. No, there are absolutely no side effects. RFQMR therapy is non ionizing, non thermal, and completely safe.


Q6. What is the typical duration of this treatment?

Ans. The treatment is usually for one hour daily over a period of 28 days.


Q7. How do i know my condition can be cured by RFQMR?

Ans. Each patients treatment will be determined by a Acelixir trained and certified doctor, who will take up the course of treatment to be administered on a case by case basis. Clinical Trials have inidcated that RFQMR therapy is extremely effective in curing arthritis.


Q8. Can the RFQMR treatment also cure cancer?

Ans. While preliminary clinical trials have demonstrated some success in destroying certain types of tumours, and relieving patients of certain symptoms, the cancer treatment is still in the intial phase of deployment, unlike Osteo arthiritis where it is a proven treatment.


Q9. What exactly is tissue engineering?

Ans. Tissue Engineering is the field of altering, modifying, controlled reproduction and controlled regeneration and degeneration of biological tissue. Using Tissue engineering techniques, today it is possible to regenerate dying tissues and organs inside the body, grow new blood vessels, heal wounds or fix an adamant fracture, grow new cartilage or even teach a few lessons to cancerous cells that go into a multiplication spree.Hence RFQMR is one of the tools which aides medical professionals to regenerate dying tissue.     


Q10. Which conditions are treatable with RFQMR?

Ans.  Based on the results of Initial Clinical Studies RFQMR is presently used for:

  • Cartilage regeneration in Osteoarthritis

  • As an alternative to knee surgery

  • For 'no side effects'  cancer tumour treatment.

  • Currently reasearch is under way for treatments for Obseity, and as soon as these cilincal trials are successfully completed the equipment maybe used for treating the same.       


Q11. Does this treatment really work?

Ans. In a clinical trial conducted on 380 knee joints, as part of technology evaluation programme, as required by Medical Devices Directive (MDD), significant effects were observed. The study has proved that the increase in cartilage thickness is only due to RFQMR therapy


Q12. Where is this treatment available?

Ans. Currently available in the following countries:


  • India

  • Pakistan

  • Honk Kong

  • Singapore

  • Canada

  • Hungary

  • Malaysia     


Q13. What is the cost of this treatment?

Ans. RFQMR treatment is fairly affordable,

While costs can vary from case to case, the approximate cost to patients will be around $3000 - 5000 USD.

The cost of the treatment is also covered by health insurance.     



For Doctors


Q1. What is RFQMR?

Ans. RFQMR is based on an innovative technology that applies low spectrum (non ionising and non thermal), radio frequency (RF) carrier modulated therapeutic signals in the presence of high instantaneous magnetic field to induce controlled therapeutic quantum magnetic resonance. This is applied in regenerative and degenerative medicine by altering cellular signaling pathways thus inducing apoptosis or controlled mitosis in tissue regeneration.


Generically referred to as Rotational Field Quantum Magnetic Resonance Therapy (or simply QMRT®), RFQMR delivers complex modulated beams in the radio frequency band, with a near field multi - harmonic delivery system using specialized helical antennae. When appropriately controlled, it can alter the TMP to specific requirements like stimulation and synthesis of the HSP group of proteins in cartilage regeneration or the p53 group of proteins in case of malignant diseases. The delivered instantaneous mode wide or narrow spectrum magnetic and RF modulations are highly cell and site specific based on proton density, permittivity, permeability and depth of penetration of the target tissue.     


Q2. What is the QMRT approach?

Ans. Like any other tissues, bone and cartilage are constantly being built up and broken down by various metabolic and physical infl¬uences. The major stimulus for the formation of bone and cartilage is a signal that is generated when these structures are subjected to tension or compression. This signal is also impaired following joint injury due to trauma or diseases such as Osteoarthritis.


Trans Membrane Potential (TMP) is a well known cellular signaling pathway that regulates the synthesis of various proteins at the appropriate time in living cells. Many non-communicable illnesses like cancer, heart diseases and degenerative disorders like cartilage loss and different kinds of in¬flammation are also linked to disturbances in protein transcription process (Cone CD., Variation of trans-membrane potential as a basic mechanism of mitosis control: Oncology: 1970; 24:438-470). It was thought during the last few decades that if an appropriate method can be developed to alter TMP in a controlled manner, most of these disorders that are protein linked could be treated and cured.


QMRT produces the required signal to initiate regenerative activities by resetting the protein pathways that has ceased to restart, therefore regenerating the degenerated cartilage, this leads to growth of new cartilage tissue or chondrogenesis, thus relieving chronic pain and disability of the joint without surgical intervention.     


Q3. What is the clincial efficacy of the RFQMR (QMRT) treatment?

Ans. QMRT® is the latest treatment option available for cartilage regeneration which when adopted may avoid or postpone surgery. This treatment requires no medication, is less expensive and a sustainable solution for cartilage loss with no known adverse effects. The treatment method involves exposure of the affected joint to the modulated radio beams that is generated by QMRT®. Each exposure last about 30 to 60 minutes everyday for about 21 days. Special MRI - Proton Density sequence is required for dosimetry and diagnostic MRI are used to evaluate the patients before the treatment, and 90 days post treatment to examine efficacy and the extent of cartilage growth. This pre and post evaluation is carried out using 3D FLASH sequence with water excitation - a gold standard in cartilage delineation and assessment.


In a clinical trial conducted on 380 knee joints, as part of technology evaluation programme, as required by Medical Devices Directive (MDD), significant effects were observed. The study has proved that the increase in cartilage thickness is only due to QMRT® therapy (F=770.802; P=0.00E+00).


Statistically, the data was examined for normality of distribution using Shapiro Wilk’s ‘W’ statistic. To compare the physical attributes of subjects, an unpaired ‘t’ test was used. Correlation coefficients were calculated between increase in the thickness of cartilage and physical attributes to examine if latter were influencing the former. For the rest of data (thickness of cartilage, pain, range of movement, Total Knee Score (TKS) and Total Functional Score (TFS)), a three way analysis of variance (ANOVA) was employed with gender and laterality as grouping variables. Correlation coefficients were computed, in the data pooled for two genders, to  find out association between growth of cartilage and physical attributes.


All data are presented as mean ± SD. Level of significance was set at P<0.05. However, exact significance is annotated in tables presenting the outcome of analysis.     


Q4. Results and Outcomes of Clinical Trials?

Ans. A significant effect of the treatment was observed on all the variables studied (refer table 4). There were no gender based differences in the responsiveness to treatment as evident from an insignificant interaction effects between gender and laterality (refer 1x3; table 4). Similarly, there was no laterality effect in response to treatment as evident from an insignificant interaction of laterality with treatment (refer 2x3; table 4). Increase in thickness of cartilage (difference between the pre and post treatment values) had no worthwhile correlation with any physical attributes (refer table 5). Thus increase in cartilage thickness is due to the effect of QMRT® treatment only. 



Q5. Conclusions of Clincial Trials?


  • Significant main effect, i.e. the increase in cartilage thickness, is due to the treatment only (F = 770.802; P = 0.00E + 00). 

  • There was no gender difference in the response to the treatment.

  • There was no laterality effect in response to the treatment. 

  • Significant reduction in pain, increased range of movements, better joint stability. 

  • Significant improvement in general quality of life.

  • “QMRT® is the only known modality that proves cartilage re-growth”.     


Q6. Which conditions are treatable with RFQMR (QMRT) therapy?

Ans. Based on the results of Initial Clinical Studies QMRT is presently used for:

  • Cartilage regeneration in Osteoarthritis

  • As an alternative to knee surgery

  • For 'no side effects'  cancer tumour treatment.

  • Currently reasearch is under way for treatments for Obseity, and as soon as these cilincal trials are successfully completed the equipment maybe used for treating the same.       


Q7. Technical specifications of RFQMR (QMRT)?


Ans. Classification: Class IIa Medical Device.
Indication of use: The Device is intended to be used for Regenerative and Degenerative Tissue Engineering i.e. it can be used for regenerating tissues in-situ and to cause degeneration of uncontrolled growth of tissues. 
Regeneration of tissues the current indication is for use in protein linked degenerative disorders like Osteoarthritis enabling regrowth of tissue like articular cartilage.


Contraindications: Critically ill patients on life support system, pregnancy, patients unable to lie down for the duration of theraphy, Patients with electrically, Magnetically or mechanically activated implants. (e.g. cardiac pacemakers, Bio stimulators, Neuro stimulators, cochlear implants, hearing aids). 

MRI Incompatible implants near the target region. E.g. intra medullary nail, intracranial aneurysm clips, stents, intra orbital metal fragments etc. 


Patients with concomitant neoplastic disease especially chondrosarcoma. 


Drug and other device interactions: The following group of drugs that use the same or similar cellular pathways as QMRT® may interact with the QMRT exposure; like Calcium Channel Blockers and Proton Pump Inhibitors, NSAIDs and Alkaloids (also food containing alkaloids) for all cellular regenerative protocol. Patients should be advised to take medication with different mode of action.


Ionizing radiations are known to damage multiplying (mitotic) cells. Hence exposure to X-ray or CT imaging of the affected joint should be avoided for atleast 12 weeks after therapy. However this will not impose any risk to the patient, in case imaging is inevitable, MRI may be advised.


Product Specifications: The power supply QMRT must meet these specifications:

a. Voltage fluctuation+/- 10% or less

b. Voltage imbalance +/- 3% or less

c. Frequency variation +/- 4% or less

d. Voltage distortion THD = 10% or less


Recommended environmental specifications: Operating Temperature range 18°C to 30°C, Humidity range 10% to 75% RH, Atmospheric pressure 700 to 1060 hPa, Transport / Storage Temperature range 10°C to 80°C, Humidity range 10% to 90% RH, Atmospheric pressure 500 to 1060 hPa.


Mode of usage:Continuous

Life of the equipment:Typically assessed at about ten years

Typical operating voltage:230 V, 50 Hz, single phase

Maximum operating current:12 Amps

Typical operating current:6A

IEC classification:Type B, Class 1, IPX0

MDD classification:Class IIa

Target resolution:11.25 degrees

Power supply type:Medical grade switch mode power supply complying with EN 60601-1, EN 60601-1-2


Frequency band: VLF, LF, HF and VHF radio bands


Instantaneous magnetic field strength: 1mT to 6T for the time duration 2.0μsec to10msec depends on the treatment and Dosimetry value.

E-Field: Broadband; average 100 dB V/m/MHz @ 4MHz

H-Field: Broadband; 20dB (below 1 kHz)

Broadband common mode current in control cables:  100dBmA/MHz @ 150 kHz

Fuses: Mains Fuse-12A, Isolation Transformer Fuse-2.5A


Laser Guiding System:Output: 625 to 680 nanometer wave length less than 5 mill watt, Complies with CFR Part 1040.10 and 1040.11 Class III A LASER application.


QMRT Guns - Magnetic field

Type: MF6040-L

Guns: K- _ Ferrite type; Near Field; gain; 10dB

Typical voltage: 60 Volts

Typical current: 4 Amps 


Radio frequency

Type of antenna: Helical

Q factor of the antenna: 560

Antenna gain: 13 dB

Centre frequency: 68.4 MHz

3dB BW (Bandwidth): ±4 MHz

6dB BW (Bandwidth): ±10 MHz

Input impedance: 50 OHM


Input connector : SMA


Physical Dimensions

Cytotron device dimensions:        4500mm (L) x 1210mm (W) x 1600mm (H)

                                                             Weight: approx. 1900 Kg

Central control unit dimensions: 1600mm (L) x 780mm (W) x 1455mm (H)

                                                             Weight: approx. 200 Kg

Coating:                                      Powder coating/Paint and Lacquer coating body  for scratch    protection and prevent from corrosion

Patient weight:                         Max. 157 Kg

Patient bed weight:                 12.95 Kg (Part No: SCL-A-01-LB)

Earthing clip weight:               50 Gms (Part No: SCL-A-02-EP)

Patient transmission system: 22 Kg

(Acrylic Sheet + Metal Frame)


Total bed safe working load:   170 Kg 


Standard applied:BS EN 980:2008, BS EN 1041:2008, BS EN 62366:2008, IEC 60601-1, IEC 60601-1-1, IEC 60601-1-2, IEC 62304, ISO 9001:2008, ISO 13485:2003, ISO 14971:2007, ISO 14155-1:2003, ISO 14155-2:2003.

Approvals: ISO 9001:2008, ISO 13485:2003

Accreditations: ANAB, UKAS, CMDCAS

Product certification:Annex II of MDD 93/42/EEC as Amended by 2007/47/EC



Q8. Medical Approvals?


Ans. ISO 9001:2008, ISO 13485:2003.

Accredations : ANAB, UKAS, CMDCAS     


Q9. What is the number of centers providing this treatment and currently operational?

Ans. The following centers are currently operational:


  • Research & Development Centre: Scalene Cybernetics, S-CARD Campus, Seegehalli Main Road, Virgonagar, Bangalore 560049 Tel: 91 80 2561 4879 

  • Treatment Centres: Ojus Niramaya Clinic, SRIT House, #113/1B, ITPL Main Road, Kundalahalli, Bangalore 560 037 Tel: 91 80 4160 4765, 91 80 4207 9708 Mob: +91 974 111 8867 (Dr GS Nayar) 

  • Care Plus, 5/1, Rudrakshini, Hayavadana Road, Gavipuram Ext, Bangalore 560 019 Tel: 91 80 2662 0069/70 Mob: +91 984 504 0984 ( Dr KP Loknath Kumar) 

  • Sibia Medical Centre, B/XIX-568 A, Civil Lines, Ludhiana - 141001 Tel: 91 161 244 4818 Mob: + 91 98140 34818 (Dr SS Sibia)

  • Innovative Joints Rejuvination Center (IIJRC), Gautam Hospital Campus, Panayapilly, Kochi, Kerala 682005, Tel : +91 484 2116237

  • Advanced Knee care Private Limited, 610 New Delhi House, 27 Barakhamba Road, New Delhi – 110 001. 

  • Best Rich Treasure Limited, Unit 820 & 828,8/F, Metro Centre-132, Lam Hing Street, Kowloon Bay, Kowloon, Hong Kong 

  • Golden M Corporate Services SDN BHD, Unit B -3-8, Megan Philso, Jalan Tun Razak 50400, Kuala Lumpur, Malaysia 

  • KKT International Spine Center, Al Bateen Area, Street #15, Villa #2, Next to American Community School, Behind Abu Dhabi Motors/ BMW Showroom, Abu Dhabi, U.A.E 

  • Life Heart -Chest & Vascular Centre, Suite 1-17, Glneagles Intan Medical Centre, 282 Jalan Ampang, 50450, Kuala Lumpur, Malaysia 

  • National Orthopaedic Center, Seethammadhara, Visakhapatnam – 530 013. 

  • Samarpan Heart Hospital & Research Center, Dwarka Highway Road, Opp Octroi Naka, Jamnagar - 361 004

  • SBF Healthcare Pvt Ltd, Shivas No. 39/4 DoddaneKundi, Marthahalli Outer Ring Road, Bangalore - 560 037

  • Safe Health, 6-3-252/B/8, Erramanzil colony, Taj Krishna Road, Near Panchayat Raj Office, Hyderabad - 500 003. 

  • SBF Healthcare Pvt Ltd, 1st Floor, JMC House, Bisleri Compound, Andheri Ghatkopar Link Road, Andheri East, Mumbai - 400 099.

  • Safe Health Knee Joints Center, 8-2-608/1/1/A, Ground Floor, Farhathmanzil, Road No.10, Banjara Hills, Hyderabad - 500 034.

  • Scalene Asia Pacific Sdn Bhd, Unit 318, Block B2, Leisure Commerce Square, No.9, Jalan PJS 8/9, 46150 Petaling Jaya Selangor Darul Ehsan, Malaysia.

  • Scalene Medical, Escher Oren 11, 2316ET Lei Den, The Netherlands. 

  • Scalene International Pvt Ltd, 10 Anson Road, #18-23, International Plaza, Singapore - 079903

  • Valuetech, 3102 Safwa Commercial Centre, Riyadh, Saudi Arabia


Q10. How can i get trained to use this?

Ans. Acelixir will arrange all training directly with the manufacturer at Bangalore. Make the training program a profit center. 3 day training program.


Q11. What will be the duration of the training?

Ans. The training will be for 3 days, at the manufacturers facility in Bangalore.


Q12. What will be the cost of the training?

Ans. There will be no cost for franchisees, for everyone else costs will apply.